# Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users

> **NCT02445339** · PHASE4 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 50 (actual)

## Conditions studied

- Alcohol Dependence
- Alcohol Use Disorder

## Interventions

- **DRUG:** XR-NTX+CM (Extended-Release Naltrexone plus Care Management)

## Key facts

- **NCT ID:** NCT02445339
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2019-02-08
- **Final completion:** 2019-02-08
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02445339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02445339, "Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02445339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*